Gubra A/S/DKr GUBRA

08:00
10:00
12:00
13:55
15:55
1D1W1MYTD1Y5YMAX

About Gubra A/S

Gubra A/S is a biotechnology company based in Denmark, focusing on pre-clinical contract research and drug discovery. It specializes in the development of peptide-based therapeutics and provides services in areas such as obesity, diabetes, and NASH (non-alcoholic steatohepatitis). The company was founded in 2008 and operates from its headquarters in Hørsholm, Denmark. Gubra differentiates itself through its integrated approach combining histology, imaging, and bioinformatics to deliver comprehensive research services. Its strategic positioning leverages cutting-edge technology to support pharmaceutical companies in early-stage drug development.

Ticker

DKr GUBRA
Sector

Primary listing

CSE

Employees

275

Headquarters

Horsholm, Denmark

Gubra A/S Metrics

BasicAdvanced
kr 6.4B
3.84
kr 102.70
0.16
kr 61.20
15.53%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy DKr GUBRA

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs